Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mary Bessesen

Concepts (203)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiratory Protective Devices
6
2021
13
2.880
Why?
Health Personnel
10
2021
520
1.690
Why?
Infection Control
7
2019
137
1.670
Why?
Methicillin-Resistant Staphylococcus aureus
5
2016
175
1.650
Why?
Staphylococcal Infections
5
2016
323
1.450
Why?
Respiratory Tract Infections
5
2021
292
1.400
Why?
Bacteremia
5
2020
159
1.250
Why?
Equipment Reuse
2
2015
10
1.160
Why?
Cross Infection
5
2016
203
1.160
Why?
Disinfection
2
2015
82
1.080
Why?
Masks
4
2021
32
1.040
Why?
Veterans
3
2020
973
0.880
Why?
Carrier State
3
2016
55
0.870
Why?
Rifampin
1
2020
75
0.760
Why?
Diabetic Foot
1
2020
57
0.750
Why?
Osteomyelitis
1
2020
110
0.700
Why?
Amputation
1
2020
188
0.680
Why?
Influenza, Human
5
2022
519
0.680
Why?
Nose
2
2015
53
0.670
Why?
Pre-Exposure Prophylaxis
1
2018
164
0.590
Why?
Anti-HIV Agents
2
2018
694
0.550
Why?
HIV Infections
3
2018
2514
0.490
Why?
Medication Adherence
1
2018
574
0.470
Why?
AIDS-Related Opportunistic Infections
4
1999
119
0.460
Why?
Occupational Exposure
2
2019
312
0.430
Why?
Polymers
1
2015
479
0.420
Why?
Antiretroviral Therapy, Highly Active
1
2012
277
0.410
Why?
Osteoporosis
1
2012
201
0.400
Why?
Catheters, Indwelling
1
2010
86
0.390
Why?
Catheter-Related Infections
1
2010
59
0.390
Why?
Microbiota
1
2015
508
0.380
Why?
Catheterization, Central Venous
1
2010
83
0.380
Why?
Delivery of Health Care
6
2022
744
0.380
Why?
Escherichia coli Infections
2
2013
125
0.340
Why?
Influenza Vaccines
2
2022
473
0.310
Why?
Elastomers
2
2015
27
0.280
Why?
Humans
35
2022
115152
0.280
Why?
Acquired Immunodeficiency Syndrome
2
1999
218
0.270
Why?
Mycobacterium avium
1
2004
19
0.260
Why?
Liver Cirrhosis, Alcoholic
1
2004
19
0.260
Why?
Molecular Typing
1
2013
18
0.260
Why?
Mycobacterium avium-intracellulare Infection
2
2004
60
0.250
Why?
Peritonitis
1
2004
79
0.250
Why?
Polymerase Chain Reaction
3
2015
1048
0.250
Why?
Drug Resistance, Multiple, Bacterial
1
2013
64
0.240
Why?
Feasibility Studies
2
2015
759
0.230
Why?
Coronavirus OC43, Human
1
2021
4
0.230
Why?
Orthomyxoviridae Infections
1
2022
51
0.220
Why?
Escherichia coli
2
2013
798
0.210
Why?
Influenza A Virus, H1N1 Subtype
1
2022
144
0.200
Why?
Male
16
2020
60974
0.200
Why?
Viruses
1
2021
93
0.200
Why?
Anti-Bacterial Agents
4
2020
1377
0.190
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2019
21
0.190
Why?
Placebos
1
2020
212
0.190
Why?
Hepatitis B, Chronic
1
1999
17
0.190
Why?
Staphylococcus aureus
2
2015
380
0.190
Why?
Attitude
1
2021
237
0.190
Why?
Lamivudine
1
1999
56
0.190
Why?
Foot
1
2020
120
0.180
Why?
Antibiotic Prophylaxis
1
2020
91
0.180
Why?
Outpatients
1
2021
269
0.180
Why?
Financing, Government
1
1999
51
0.180
Why?
Mandatory Programs
1
2018
17
0.170
Why?
Nasal Cavity
2
2016
50
0.170
Why?
Secondary Prevention
1
2020
256
0.170
Why?
Middle Aged
9
2020
28958
0.170
Why?
Female
12
2020
63300
0.170
Why?
Adult
11
2020
32204
0.170
Why?
Sterilization
1
2017
17
0.170
Why?
Retrospective Studies
6
2020
11727
0.150
Why?
Antibiosis
1
2015
7
0.150
Why?
Streptococcus mitis
1
2015
8
0.150
Why?
Lactobacillus
1
2015
25
0.150
Why?
Vaccination
3
2021
1094
0.150
Why?
Nasal Mucosa
1
2016
95
0.140
Why?
Sulfadoxine
1
1995
4
0.140
Why?
Pyrimethamine
1
1995
2
0.140
Why?
Catalase
1
2015
135
0.140
Why?
Tertiary Care Centers
1
2016
129
0.140
Why?
Double-Blind Method
1
2020
1682
0.140
Why?
Pneumonia, Pneumocystis
1
1995
35
0.140
Why?
Disease Transmission, Infectious
1
2015
64
0.140
Why?
Equipment Contamination
1
2015
51
0.140
Why?
Treatment Outcome
4
2020
9219
0.140
Why?
Sequence Analysis, DNA
2
2015
735
0.140
Why?
Cost-Benefit Analysis
1
2017
556
0.130
Why?
Occupational Diseases
1
2016
146
0.130
Why?
Efficiency, Organizational
2
2018
137
0.130
Why?
Reference Standards
1
2015
195
0.130
Why?
Virus Diseases
1
2016
190
0.130
Why?
Risk Factors
4
2021
9105
0.130
Why?
Task Performance and Analysis
1
2015
186
0.130
Why?
Medical Errors
1
2015
103
0.130
Why?
Prospective Studies
3
2020
6324
0.130
Why?
Aged
3
2020
20309
0.130
Why?
HIV-1
1
1999
790
0.120
Why?
RNA, Ribosomal, 16S
1
2015
476
0.120
Why?
Mycobacterium Infections
1
1993
64
0.120
Why?
Cohort Studies
3
2020
5026
0.120
Why?
Follow-Up Studies
2
2018
4959
0.120
Why?
Bone Density Conservation Agents
1
2012
62
0.120
Why?
Osteoporotic Fractures
1
2012
46
0.110
Why?
Prevalence
2
2013
2403
0.110
Why?
United States Department of Veterans Affairs
1
2015
526
0.110
Why?
Risk Assessment
2
2016
3215
0.110
Why?
Incidence
2
2019
2456
0.100
Why?
Ergonomics
1
2010
21
0.100
Why?
Listeria monocytogenes
1
1990
94
0.100
Why?
Metagenome
1
2010
111
0.090
Why?
United States
4
2018
12598
0.090
Why?
Hospitalization
2
2015
1727
0.090
Why?
Molecular Epidemiology
2
2013
59
0.090
Why?
Aged, 80 and over
1
2020
6845
0.080
Why?
Drug Therapy, Combination
2
2004
1007
0.080
Why?
Cytosine
1
2005
49
0.070
Why?
Organophosphonates
1
2005
97
0.070
Why?
Herpes Simplex
1
2005
100
0.070
Why?
Immunocompetence
1
2004
46
0.070
Why?
Ambulatory Care
2
2019
463
0.070
Why?
Adolescent
3
2020
18716
0.060
Why?
Young Adult
1
2020
11032
0.060
Why?
Fluoroquinolones
1
2013
42
0.060
Why?
beta-Lactams
1
2013
23
0.060
Why?
Inpatients
2
2020
353
0.060
Why?
Infusions, Intravenous
1
2004
406
0.060
Why?
Hemagglutination Inhibition Tests
1
2022
39
0.060
Why?
Influenza A Virus, H3N2 Subtype
1
2022
32
0.060
Why?
Virulence Factors
1
2013
139
0.060
Why?
Escherichia coli Proteins
1
2013
171
0.060
Why?
Hepatitis B e Antigens
1
1999
2
0.050
Why?
Antiviral Agents
1
2005
648
0.050
Why?
Drug Resistance
1
1999
185
0.040
Why?
Program Evaluation
2
2015
877
0.040
Why?
Antibodies, Viral
1
2022
543
0.040
Why?
Treatment Failure
1
1999
336
0.040
Why?
Absenteeism
1
2018
39
0.040
Why?
Genotype
1
2013
1854
0.040
Why?
Surgical Instruments
1
2017
43
0.040
Why?
Operating Rooms
1
2017
82
0.040
Why?
Hospital Costs
1
2017
126
0.040
Why?
Recurrence
1
1999
990
0.040
Why?
Hand Hygiene
1
2015
6
0.040
Why?
Immunization Programs
1
2018
208
0.040
Why?
Pentamidine
1
1995
4
0.040
Why?
Seasons
1
2018
438
0.040
Why?
Communicable Diseases, Emerging
1
2015
30
0.040
Why?
Personal Protective Equipment
1
2015
42
0.040
Why?
Severity of Illness Index
1
2004
2853
0.040
Why?
Zidovudine
1
1995
80
0.030
Why?
Health Policy
1
2018
361
0.030
Why?
Workplace
1
2016
248
0.030
Why?
Administration, Inhalation
1
1995
673
0.030
Why?
Occupational Health
1
2015
211
0.030
Why?
Global Health
1
2015
346
0.030
Why?
Digestive System
1
1991
26
0.030
Why?
Environmental Exposure
1
2015
394
0.030
Why?
Listeria
1
1990
4
0.030
Why?
Patients' Rooms
1
2010
9
0.030
Why?
Time and Motion Studies
1
2010
30
0.030
Why?
Manikins
1
2010
28
0.030
Why?
Facility Design and Construction
1
2010
16
0.030
Why?
Hand Disinfection
1
2010
16
0.030
Why?
Mycobacterium Infections, Nontuberculous
1
1995
280
0.030
Why?
Diarrhea
1
1991
178
0.030
Why?
Bacterial Typing Techniques
1
2010
39
0.030
Why?
Evaluation Studies as Topic
1
1990
219
0.030
Why?
Colony Count, Microbial
1
2010
85
0.030
Why?
DNA, Ribosomal
1
2010
84
0.030
Why?
Quality Control
1
2010
166
0.020
Why?
Health
1
2010
74
0.020
Why?
Feedback
1
2010
147
0.020
Why?
Staphylococcus epidermidis
1
2010
70
0.020
Why?
Checklist
1
2010
75
0.020
Why?
Workload
1
2010
136
0.020
Why?
Problem Solving
1
2010
161
0.020
Why?
Species Specificity
1
1990
619
0.020
Why?
Time Factors
2
2010
7041
0.020
Why?
Equipment Design
1
2010
533
0.020
Why?
Cues
1
2010
304
0.020
Why?
Residence Characteristics
1
2010
287
0.020
Why?
Community-Acquired Infections
1
2009
134
0.020
Why?
DNA, Bacterial
1
2009
301
0.020
Why?
Attention
1
2010
465
0.020
Why?
Biodiversity
1
2010
350
0.020
Why?
Intensive Care Units
1
2010
599
0.020
Why?
Motivation
1
2010
516
0.020
Why?
Sensitivity and Specificity
1
1990
1922
0.020
Why?
Simplexvirus
1
2005
94
0.020
Why?
Child
2
2021
17939
0.020
Why?
Drug Resistance, Viral
1
2005
101
0.020
Why?
Molecular Sequence Data
1
2010
3014
0.020
Why?
Bacteria
1
1990
661
0.020
Why?
Bone Marrow Transplantation
1
2005
268
0.020
Why?
Longitudinal Studies
1
2010
2676
0.010
Why?
Life Tables
1
1995
27
0.010
Why?
Mycobacterium avium Complex
1
1995
87
0.010
Why?
Australia
1
1995
228
0.010
Why?
CD4 Lymphocyte Count
1
1995
290
0.010
Why?
Europe
1
1995
334
0.010
Why?
North America
1
1995
273
0.010
Why?
Survival Rate
1
1995
1862
0.010
Why?
Case-Control Studies
1
1995
3261
0.010
Why?
Bessesen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)